The common drug review is where federal, provincial, and territorial drug plan managers sit at the table, but the recommendation they make is to the provinces on the participating plans. They actually decide what to put on the formulary according to the plans.
They look at the impact on the provincial budgets. For Atlantic Canada, where they don't have the tax base or the population numbers, it's extremely difficult for them to afford to put on more drugs. For access in Alberta, they list 12 of the 17 drugs that have been approved. It's Ontario, with the full listing of only six, that we have a question mark around, in particular. It depends on where you live and on the provincial decision as to whether or not the drugs are listed.
Until the common drug review takes everyone to the table and does a bigger analysis on what should be available for questions of fairness, in our view, you're always going to have this challenge. It is why we consistently ask for a national catastrophic drug plan, because it's the only way we're going to get to a consistent national standard.